A detailed history of Argi Investment Services, LLC transactions in Alaunos Therapeutics, Inc. stock. As of the latest transaction made, Argi Investment Services, LLC holds 13,000 shares of TCRT stock, worth $9,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,000
Previous 13,100 0.76%
Holding current value
$9,100
Previous $23,000 65.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

SELL
$0.5 - $1.19 $50 - $119
-100 Reduced 0.76%
13,000 $8,000
Q2 2022

Jul 26, 2022

BUY
$0.41 - $1.24 $41 - $124
100 Added 0.77%
13,100 $16,000
Q3 2021

Nov 10, 2021

BUY
$1.44 - $2.73 $18,720 - $35,490
13,000 New
13,000 $24,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $151M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Argi Investment Services, LLC Portfolio

Follow Argi Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argi Investment Services, LLC with notifications on news.